Isabella Cascino, Giuliana Papoff, Adriana Eramo, and Giovina Ruberti

Department of Immunobiology, Institute of Cell Biology, National Research Council, Rome, Italy.

Received 12/01/95; Accepted 01/11/96; On-line 1/1/96

1. M. C. Raff: Social controls on cell survival and cell death. Nature 356, 397-400 (1992)

2. J. F. Kerr, A. H. Wyllie & A. R. Currie: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26, 239-57 (1972)

3. A. H. Willye, J. F. R. Kerr & A. R. Currie: Cell death: the significance of apoptosis. Int Rev Cytol 68, 251-306 (1980)

4. N. Itoh, S. Yonehara, A. Ishii, M. Yonehara, S. Mizushima, M. Sameshima, A. Hase, Y. Seto & S. Nagata: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66, 233-43 (1991)

5. A. Oehm, I. Berhmann, W. Falk, M. Pawlita, G. Maier, C. Klas, M. Li-Weber, S. Richards, J. Dhein, B. C. Trauth, H. Ponstingl & P. H. Krammer: Purification and molecular cloning of the Apo-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J Biol Chem 267, 10709-15 (1992)

6. C. A. Smith, T. Farrah & R. G. Goodwin: The TNF receptor superfamily of cellular and viral proteins: activation, costimulation and death. Cell 76, 959-62 (1994)

7. B. C. Trauth, C. Klas, A. M. J. Peters, S. Matzuku, P. Moller, W. Falk, K.- M. Debatin & P. H. Krammer: Monoclonal antibody mediated tumor regression by induction of apoptosis. Science 245, 301-5 (1989)

8. S. Yonehara, A. Ishii & M. Yonehara: A cell killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of TNF. J Exp Med 169, 1747-56 (1989)

9. T. Suda & S. Nagata: Purification and characterization of the Fas ligand that induces apoptosis. J Exp Med 179, 873-9 (1994)

10. T. Suda, T. Takahashi, P. Golstein & S. Nagata: Molecular cloning and expression of the Fas ligand, a novel member of the TNF family. Cell 75, 1169-78 (1993)

11. T. Takahashi, M. Tanaka, J. Inazawa, T. Abe, T. Suda & S. Nagata: Human Fas ligand: gene structure, chromosomal location and species specificity. Int Immunol 6, 1567-74 (1994)

12. T. Takahashi, M. Tanaka, C. I. Brannan, N. A. Jenkins, N. G. Copeland, T. Suda & S. Nagata: Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76, 969-76 (1994)

13. D. H. Lynch, M. L. Watson, M. R. Alderson, P. R. Baum, R. E. Miller, T. Tough, M. Gibson, T. Davis-Smith, C. A. Smith, K. Hunter, D. Bhat, W. Din, R. G. Goodwin & M. F. Seldin: The mouse Fas ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity 1, 131-6 (1994)

14. C. B. Thompson: Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456-62 (1995)

15. S. Nagata & P. Golstein: The Fas death factor. Science 267, 1449-56 (1995)

16. R. Watanabe-Fukunaga, C. I. Brannan, N. G. Copeland, N. A. Jenkins & S. Nagata: Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356, 314-7 (1992)

17. M. Adachi, R. Watanabe-Fukunaga & S. Nagata: Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc Natl Acad Sci USA 90, 1756-60 (1993)

18. S. Kobayashi, T. Hirano, M. Kakinuma & T. Uede: Transcriptional repression and differential splicing of Fas mRNA by early transposon (ETn) insertion in autoimmune lpr mice. Biochem Biophys Res Commun 191, 617-24 (1993)

19. J. Wu, T. Zhou, J. He & J. D. Mountz: Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J Exp Med 178, 461-8 (1993)

20. B. J. L. Chu, J. Drappa, A. Parnassa & K. B. Elkon: The defect in Fas mRNA expression in MRL/lpr mice is associated with insertion of the retrotrasposon ETn. J Exp Med 178, 723-30 (1993)

21. F. Rieux-Laucat, F. Le Deist, C. Hivroz, I. A. G. Roberts, K-. M. Debatin, A. Fischer & J. P. de Villartay: Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268, 1347-9 (1995)

22. G. H. Fisher, F. J. Rosenberg, S. E. Straus, J. K. Dale, L. A. Middelton, A. Y. Lin, W. Strober, M. J. Lenardo & J. M. Puck: Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81, 935-46 (1995)

23. X. Su, T. Zhou, Z. Wang, P. Yang, R. S. Jope & J. D. Mountz: Defective expression of hematopoietic cell protein tyrosine phosphatase (HCP) in lymphoid cells blocks Fas-mediated apoptosis. Immunity 2, 353-62 (1995)

24. T. Sato, S. Irie, S. Kitada & J. C. Reed: FAP-1: a protein tyrosine phosphatase that associates with Fas. Science 268, 411-5 (1995)

25. R. C. Bargou, P. T. Daniel, M. Y. Mapara, K. Bommert, C. Wagener, B. Kallinich, H. D. Royer & B. Dorken: Expression of the bcl-2 gene family in normal and malignant breast tissue: low bax-alpha expression in tumor cells correlates with resistance towards apoptosis. Int J Cancer 60, 854-9 (1995)

26. I. Cascino, G. Papoff, R. De Maria, R. Testi & G. Ruberti: Fas/Apo-1/CD95 receptor lacking the intracytoplasmic signaling domain protects tumor cells from Fas-mediated apoptosis. J Immunol 156, 13-17 (1996)

27. M. G. Cifone, P. Roncaioli, R. De Maria, G. Camarda, A. Santoni, G. Ruberti & R. Testi: Multiple pathways originate at the Fas/Apo-1 (CD95) receptor: sequential involvement of phosphatidylcholine-specific phospholipase C and acidic sphingomyelinase in the propagation of the apoptotic signal. EMBO J 14, 5859-68 (1995).

28. J. Cheng, T. Zhou, C. Liu, J. P. Shapiro, M. J. Brauer, M. C. Kiefer, P. J. Barr & J. D. Mountz: Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 263, 1759-62 (1994)

29. I. Cascino, G. Fiucci, G. Papoff & G. Ruberti: Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. J Immunol 154, 2706-13 (1995)

30. G. Papoff, I. Cascino, A. Eramo, G. Starace, D. H. Lynch & G. Ruberti: An N-terminal domain shared by Fas/Apo-1 (CD95) soluble variants prevents cell death in vitro. (submitted)

31. C. Liu, J. Cheng & J. D. Mountz: Differential expression of human Fas mRNA species upon peripheral blood mononuclear cell activation. Biochem J 310, 957-63 (1995)

32. I. Behrmann, H. Walczak & P. H. Krammer: Structure of the human APO-1 gene. Eur J Immunol 24, 3057-62 (1994)

33. J. Cheng, C. Liu, W. J. Koopman & J. D. Mountz: Characterization of the human Fas gene. Exon/Intron organization and promoter region. J Immunol 154, 1239-45 (1995)

34. F. Leithauser, J. Dhein, G. Mechtersheimer, K. Koretz, S. Brunderlein, C. Henne, A. Schmidt, K. -M. Debatin, P. H. Krammer & P. Moller: Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest 69, 415-29 (1993)

35. L. B. Owen-Schaub, R. Radinsky, E. Kruzel, K. Berry & S. Yonehara: Anti-Fas mediated apoptosis in nonhematopoietic tumors: neither Fas/Apo-1 nor bcl-2 expression is predictive of biological responsiveness. Cancer Res 54, 1580-6 (1994)

36. M. Y. Mapara, R. Bargou, C. Zugck, H. Dohner, F. Ustaoglu, R. R. Jonker, P. H. Krammer & B. Dorken: APO-1 mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: correlation with bcl-2 oncogene expression. Eur J Immunol 23, 702-8 (1993)

37. K. -M. Debatin, C. K. Goldman, T. A. Waldmann & P. H. Krammer: APO-1 induced apoptosis of leukemia cells from patients with adult T-cell leukemia. Blood 81, 2972-7 (1993)

38. G. Natoli, A. Ianni, A. Costanzo, G. De Petrillo, I. Ilari, P. Chirillo, C. Balsano &M. Levrero: Resistance to Fas-mediated apoptosis in human hepatoma cells. Oncogene 11, 1157-64 (1995)

39. L. B. Owen-Schaub, L. S. Angelo, R. Radinsky, C. F. Ware, T. G. Gesner & D. P. Bartos: Soluble Fas/Apo-1 in tumor cells: a potential regulator of apoptosis. Cancer Letters 94, 1-8 (1995)

40. N. Itoh & S. Nagata: A novel protein domain required for apoptosis. J Biol Chem 268, 10932-7 (1993)

41. L. A. Tartaglia, T. M. Ayres, G. H. W. Wong, D. V. Goeddel: A novel domain within the 55 Kd TNF receptor signals cell death. Cell 74, 845-53 (1993)

42. M. G. Cifone, R. De Maria, P. Roncaioli, M. R. Rippo, M. Azuma, L. L. Lanier, A. Santoni & R. Testi: Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J Exp Med 180, 1547-52 (1994)

43. M. R. Alderson, T. W. Tough, S. Braddy, T. Davis-Smith, E. Roux, K. Schooley, R. E. Miller & D. H. Lynch: Regulation of apoptosis and T cell activation by Fas-specific monoclonal antibodies. Int Immunol 6, 1799-1806 (1994)

44. D. P. M. Hughes & I. N. Crispe: A Naturally occurring soluble isoforms of murine Fas generated by alternative splicing. J Exp Med 182, 1395-1401 (1995)

45. E. Knipping, K-. M. Debatin, K. Stricker, B. Heilig, A. Eder & P. H. Krammer: Identification of soluble APO-1 in supernatants of human B- and T-cell lines and increased serum levels in B- and T-cell leukemias. Blood 85, 1562-9 (1995)

46. R. A. Smith & C. Baglioni: The active form of tumor necrosis factor is a trimer. J Biol Chem 262, 6951-4 (1987)

47. M. J. Eck & S. R. Sprang: The structure of tumor necrosis factor at 2.6 A resolution. J Biol Chem 264, 17595-605 (1989)

48. E. Y. Jones, D. I. Stuart & N. P. C. Walker: Structure of tumor necrosis factor. Nature 338, 225-8 (1989)

49. M. J. Eck, M. Ultsch, E. Rinderknecht, A. M. deVos & S. R. Spring: The structure of human lymphotoxin (tumor necrosis factor beta) at 1.9-A resolution. J Biol Chem 267, 2119-22 (1992)

50. D. Banner, A. D'Arcy, W. Janes, R. Gentz, H-. J. Schoenfeld, C. Broger, H. Loetscher & W. Lesslauer: Crystal structure of the soluble human 55kd TNF receptor-human TNFß complex: implications for TNF receptor activation. Cell 73, 431-45 (1993)

51. M. Tanaka, T. Suda, T. Takahashi & S. Nagata: Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J 14, 1129-35 (1995)

52. A. Basu, M. Raghmath, S. Bishayee & M. Das: Inhibition of tyrosine kinase activity of the epidermal growth factor (EGF) receptor by a truncated receptor form that binds to EGF: role for interreceptor interaction in kinase regulation. Mol Cell Biol 9, 671-7 (1989)

53. L. Wang, M. Miura, L. Bergerou, H. Zhu & J. Yuan: Ich-1, an Ice/ ced-3- related gene, encodes both positive and negative regulators of programmed cell death. Cell 78, 739-750 (1994)

54. L. H. Boise, M. Gonzalez-Garcia, E. Postema, L. Ding, T. Lindsten, L. A. Turka, X. Mao, G. Nunez & C. B. Thompson : bcl-x, a bcl2-related gene that functions as a dominant negative regulator of apoptotic cell death. Cell 74, 597-608 (1993)